4.5 Review

Inflammatory Modulation of Hematopoiesis: Linking Trained Immunity and Clonal Hematopoiesis with Chronic Disorders

Journal

ANNUAL REVIEW OF PHYSIOLOGY
Volume 84, Issue -, Pages 183-207

Publisher

ANNUAL REVIEWS
DOI: 10.1146/annurev-physiol-052521-013627

Keywords

-

Categories

Funding

  1. US National Institutes of Health [DE024153, DE029436, DE026152, DE028561]
  2. German Research Foundation [CRC-TRR 127, CRC 1181, CRC-TRR 205, muBone SPP 2084, WI3291/12-1, WI3291/13-1]

Ask authors/readers for more resources

Inflammation-adapted hematopoietic stem and progenitor cells play a crucial role in emergency myelopoiesis, trained immunity, and clonal hematopoiesis. Modulation of HSPC function could lead to novel therapeutic interventions.
Inflammation-adapted hematopoietic stem and progenitor cells (HSPCs) have long been appreciated as key drivers of emergency myelopoiesis, thereby enabling the bone marrow to meet the elevated demand for myeloid cell generation under various stress conditions, such as systemic infection, inflammation, or myelosuppressive insults. In recent years, HSPC adaptations were associated with potential involvement in the induction of long-lived trained immunity and the emergence of clonal hematopoiesis of indeterminate potential (CHIP). Whereas trained immunity has context-dependent effects, protective in infections and tumors but potentially detrimental in chronic inflammatory diseases, CHIP increases the risk for hematological neoplastic disorders and cardiometabolic pathologies. This review focuses on the inflammatory regulation of HSPCs in the aforementioned processes and discusses how modulation of HSPC function could lead to novel therapeutic interventions.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available